To include your compound in the COVID-19 Resource Center, submit it here.

Hexvix: Began Phase III trial

PhotoCure ASA (OSE:PHO), Oslo, Norway
Product:

Read the full 62 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE